Precision Neuroscience gains FDA approval for BCI device within 2 years

Precision Neuroscience will receive FDA approval for its brain-computer interface device by May 2028, following the Medtronic partnership and accelerated clinical trials. Regulatory clearance will unlock commercial sales and partnerships with Medtronic.

Implied probability (Yes)

60%